Ablation of a site of progression with stereotactic body radiation therapy extends sunitinib treatment from 14 to 22 months.

C. Straka,D.W. Nathan Kim,Robert D. Timmerman,I. Pedrosa,C. Jacobs,J. Brugarolas
DOI: https://doi.org/10.1200/JCO.2012.47.7455
IF: 45.3
2013-08-10
Journal of Clinical Oncology
Abstract:
What problem does this paper attempt to address?